Melatonin exerts a variety of physiologic activities that are mainly relayed through the melatonin receptors MT 1 and MT 2 Low expressions of these receptors in tissues have led to widespread experimental use of the agonist 2-[
Introduction
The neurohormone melatonin (MLT) is produced by the pineal gland during periods of darkness, particularly at night (Arendt and Broadway, 1987; Zawilska et al., 2009 ). Melatonin pleiotropic effects include exerting control over biologic rhythms, such as circadian rhythms through the suprachiasmatic nuclei (Coomans et al., 2015) , and circannual rhythms, e.g., seasonal reproduction and molting (Lincoln et al., 2006) . The melatonergic system has been implicated in depression, leading to development of the MLT receptor-targeting antidepressive drug agomelatin (Valdoxan ® ) (Millan et al., 2003 (Millan et al., , 2005 de Bodinat et al., 2010) .
Melatonin actions are exerted through its interactions with three known targets: two of these targets are the G-protein-coupled melatonin receptors MT 1 and MT 2 (Jockers et al., 2008) , which are mainly coupled to G i protein, leading to adenylate cyclase inhibition (Brydon et al., 1999; Barrett and Bolborea, 2012) ; and the third melatonin target is quinone reductase 2 (formerly known as MT 3 ) (Dubocovich, 1988b; Paul et al., 1999; Nosjean et al., 2000) , which has raised several questions regarding melatonin mechanisms of action in some models, particularly at higher concentrations (Vella et al., 2005; Jockers et al., 2008; Boutin, 2015) . An interaction between the RAR-related orphan receptors and melatonin has been reported (Carlberg and Wiesenberg, 1995) , but remains elusive to confirmatory studies.
Prior to the cloning of these receptors in the late 1990s (Reppert et al., 1994 (Reppert et al., , 1995 , it was very difficult to study MLT binding on biologic membranes, since these receptors are naturally expressed at very low levels and the available radioligand S73893, N-[3-methoxy-2-(7-methoxy-1-naphthyl) propyl]acetamide; S75436, 2-fluoro-N-[3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]acetamide; S77834, N-[(8-methoxy-10,11-dihydro-5H-dibenzo[a,d] [7]annulen-10-yl)methyl]acetamide; S77840, 1- [(8-methoxy-10,11-dihydro-5H-dibenzo[a,d] - [7] annulen-10-yl)methyl]urea; S20928, (N-[2-(1-naphthyl) ethyl]cyclobutanecarboxamide); S21278, N-[2-(6-methoxybenzimidazol-1-yl)ethyl]acetamide; S22153, N-[2-(5-ethylbenzothiophen-3-yl) ethyl]acetamide; S27128-1, N-[2-(2-iodo-5-methoxy-6-nitro-1H-indol-3-yl)ethyl]acetamide; TESPA, 3-amino-propyl-ethoxy-silane; 2-Br-MLT, 2-bromomelatonin. (Vakkuri et al., 1984 (Vakkuri et al., , 1985 , all experiments were conducted with it.
Few diverse tools have been developed for MLT molecular pharmacology studies (Markl et al., 2011) , such as subtypespecific agonists or antagonists, or biased agonists (Devavry et al., 2012b; Legros et al., 2014) . We further screened our compounds (Yan et al., 2008) to find various types of ligands that are amenable to chemical conversion to iodinated and radioactive derivatives. Through this study, we identified an MT 2 -specific very partial agonist, 2-(2-[(2-iodo-4,5-dimethoxyphenyl)methyl]-4,5-dimethoxy phenyl) (DIV880), with a K i value that is 2 logs less potent at MT 1 than at MT 2 . We synthesized the precursors of each ligand, make them iodinated, and assessed their characteristics as binders at the recombinant human MT 1 and MT 2 receptors. This approach has been briefly described in our recent publication (Legros et al., 2013) .
In the present work, we described the behaviors of these new ligands as compared with the standard ligands [ In particular, we investigated the ligand behaviors at their respective cloned receptors, finding that two were specific to the receptor isoform MT 2 . Furthermore, we established the molecular pharmacology of MT 2 using those specific ligands, and compared it with the profiles obtained with other, nonspecific ligands (i.e., 2-[ 125 I]-MLT and [ 3 H]-MLT). This study contributes to the knowledge in this field, to help develop as many tools as possible to determine the characteristics of the purified receptors (Logez et al., 2014) as well as specific ligand(s) amenable for autoradiography in native tissues. MLT, serotonin, from SigmaAldrich (St. Louis, MO); 4P-PDOT (4-phenyl-2-propionamidotetraline) and luzindole (2-benzyl-N-acetyltryptamine) from Tocris (Bristol, UK); and 2-bromomelatonin from Toronto Research Chemicals, Inc. (North York, Canada). We also evaluated 15 analogs of MLT that stemmed from our product library . Compounds were dissolved in dimethylsulfoxide at a stock concentration of 10 mM, and stored at 220°C until use. All other reagents were obtained from Sigma-Aldrich.
Materials and Methods

Reagents and Ligands
Cell Membrane Preparation
CHO-K1 cell lines stably expressing the MT 1 or MT 2 receptor (human, rat, mouse, or sheep: hMT, rMT, mMT and oMT, respectively) were grown to confluence, harvested in phosphate-buffered saline buffer (GIBCO, Invitrogen, Cergy-Pontoise, France) containing 5 mM EDTA, and centrifuged for 20 minutes at 1000 Â g (4°C). The resulting pellet was suspended in 5 mM Tris/HCl (pH 7.4) containing 2 mM EDTA, and homogenized using a Kinematica polytron (Kinematica AG, Luzern, Switzerland). The homogenate was then centrifuged for 30 minutes at 20,000 Â g (4°C), and the resulting pellet was suspended in 75 mM Tris/HCl (pH 7.4) containing 2 mM EDTA and 12.5 mM MgCl 2 . Protein content was determined using the Bradford method (Bradford, 1976) ]-SD6), followed by incubation for increasing time periods ranging from 5 to 240 minutes. For dissociation studies, membranes were incubated with the same radioligand concentrations for 20 minutes, 1 hour, or 2 hours, followed by addition of 10 mM cold MLT to initiate dissociation, and then incubation for increasing time periods from 0 to 240 minutes. To account for membrane variability, kinetic measurements were repeated at least twice on each pool of membranes. For displacement tests, the membranes in binding buffer were first incubated with compounds diluted in 10% dimethylsulfoxide, followed by the same duration of incubation with the radioligands: [ ]-SD6, 0.08 nM for both hMT 1 and hMT 2 , 1-hour incubations for hMT 1 and 1.5-hour incubations for hMT 2 . The different incubation times were selected based on the kinetics results to be in equilibrium in accordance with the mass-action law. Ligand dilutions from 10 25 to 10 215 M were created using the MicroLab Starlet (Hamilton, Massy, France). Nonspecific binding was defined using 10 mM MLT.
Data were analyzed using the program PRISM (GraphPad Software Inc., San Diego, CA). For the saturation assay, the binding site density (B max ) and the radioligand dissociation constant (K D ) were calculated following the method of Scatchard (1949) . Association kinetics data were analyzed by fitting specific binding data to the equation B 5 B max *[1 2 exp (2k*t) ], where B is binding at time t, and k is the observed association rate constant. Dissociation kinetics data were analyzed by fitting specific binding to the equation B 5 B max *exp (2k1t) 1 plateau, where k is the dissociation constant rate. For displacement experiments, inhibition constants (K i ) were calculated using the Cheng-Prussof equation (Cheng and Prusoff, 1973) :
, where IC 50 is the 50% inhibition concentration, and L is the [
The extra sum-ofsquares F-test was used for preferred model analysis, at one or two sites, for the saturation and kinetics experiments. The Pearson productmoment correlation coefficient was used for correlation analysis of the inhibition constant values, as their log: pK i .
Tissue Membrane Preparation. Lambs and young adult sheep were obtained from the SODEM slaughterhouse in February, and were killed during the morning between 7:00 and 12:00 (Le Vigeant, France). Retinas were collected, frozen in nitrogen liquid, and stored at 280°C, with a less than 10-minute interval between slaughter and freezing. For analysis, the retinas were thawed on ice, crushed, and homogenized with a Kinematica polytron (Kinematica AG) in 4°C grinding buffer comprising 5 mM Tris/HCl and 2 mM EDTA at pH 7.4. Homogenates were then centrifuged for 12 minutes at 1000 Â g (4°C), and the supernatant was ultracentrifuged for 35 minutes at 20,000 Â g (4°C). The resulting pellets were suspended in conservation buffer comprising 50 mM Tris/HCl, 6 mM ascorbic acid, 4 mM CaCl 2 , and 4% glycerol at pH 7.4. Protein content was determined following the Bradford method (Bradford, 1976) using the Bio-Rad kit. Aliquots of the membrane preparation were stored at 280°C until use.
Tissue Membrane Saturation Assays. Tissue membrane saturation assays were performed in 96-well plates with a 250-ml final volume in binding buffer comprising 50 mM Tris/HCl, 6 mM ascorbic acid, and 4 mM CaCl 2 at pH 7.4 (with 0.1% bovine serum albumin for ]-DIV880 (0.1-2.5 nM). Nonspecific binding was defined using 10 mM MLT. Reactions were stopped by rapid filtration through GF/B unifilters, followed by three successive washes with icecold 50 mM Tris/HCl buffer (pH 7.4).
Autoradiography of Rat and Sheep Brains. Autoradiography was performed using brains from three rats and two sheep. The animals were sacrificed by decapitation, after which their brains were quickly removed and frozen over liquid nitrogen. We used a microtome-cryostat (Leitz Kryostat 1720) at 220°C to generate frozen frontal 15-mm sections throughout the rat brains, and from four regions of interest (suprachiasmatic nuclei, pars tuberalis, hypothalamus and hippocampus) from the sheep brains. These sections were collected on TESPA (3-amino-propyl-ethoxy-silane; Sigma-Aldrich, Saint-Quentin Fallavier, France) gel-coated slides (Leica Microsystemes, Nanterre, France), and stored at 280°C until incubation.
Sections were first washed with 50 mM Tris buffer at 4°C, then incubated for 1 hour at room temperature with 100 ml of (Malpaux et al., 1998) .
Autoradiograms were generated by placing air-dried sections in X-ray cassettes with Biomax MR hyperfilm (Amersham, Courtaboeuf, France). ]-S70254 binding at room temperature. To identify histologic structure, autoradiography sections were stained using the Klüver and Barrera methods (Kluver and Barrera, 1953 ) and compared with a rat brain atlas (Paxinos and Watson, 1997) . Binding intensity was assessed using an image analysis system (Biocom Histo 500, Les Ulys, France). Nonspecific binding levels were measured on the control section incubated with cold ligands. After removing these levels, the mean gray density was transformed to counts per minute using the microscale standards, and data were converted to fmol·mg protein 21 as previously described (Nazarali et al., 1989) .
Autoradiography of Rat and Sheep Retinas. Autoradiography was performed using retinas from two rats and two sheep. Sheep were sacrificed by decapitation, the eyes were quickly removed, and then the retinas were collected by scraping the back of the eyes. The collected retinas were frozen together over liquid nitrogen and then embedded in Tissue-Tek (akura Finetek Europe B.V., AV Alphen aan den Rijn, The New Melatonin Receptor Radioligands Netherlands) and used to generate 15-mm retina sections for analysis. Rats were sacrificed by decapitation, their eyes were collected, and the crystalline was removed. The eyes were then embedded together on the lateral side in Tissue-Tek, frozen over liquid nitrogen, and used to generate 15-mm sagittal sections. Binding in the rat and sheep retina tissue sections was assayed using the previously described conditions. Association and Dissociation Kinetics. Kinetics parameters were determined for each radioligand on hMT 1 and hMT 2 . Table 1 presents all kinetics parameters (k on , k off , K Dkinetics , and half-life) as the mean 6 S.E.M. from experiments with n of at least 2. The kinetics curves are presented in Fig. 1 We assessed a set of 24 compounds that were previously described in the literature [including 4-phenyl-2-propionamidotetraline (Dubocovich et al., 1997) , luzindole (Dubocovich, 1988a) , and ramelteon (Uchikawa et al., 2002) ] or that were issued from our own medicinal chemistry programs (Depreux et al., 1994;  Audinot et al., 2003 Audinot et al., , 2008 Mailliet et al., 2004; Devavry et al., 2012a,b; Ettaoussi et al., 2013; Legros et al., 2013 Legros et al., , 2014 (Fig. 3) with a pK d 1 (site 1) of 10.35 6 0.03, a pK d 2 (site 2) of 9.25 6 0.13, a B max 1 (site 1) of 1.46 6 0.13 fmol·mg protein 21 , and a B max 2 (site 2) of 2.32 6 0.98 fmol·mg protein 21 (n 5 4). Similarly, [ 125 I]-SD6 showed biphasic curves and Scatchard regressions (Fig. 3) with a pK d 1 of 10.13 6 0.18, a pK d 2 of 6.79 6 0.21, a B max 1 of 0.60 6 0.20 fmol·mg protein
Results
Characteristics of
21
, and a B max 2 5 2.11 6 1.13 fmol·mg protein
(n 5 3). Unfortunately, MT 2 radioligands did not show any proper saturation curves. Moreover, the signals of [
125 I]-S70254 were very low and highly variable, and it was not possible to obtain a saturation curve better than that shown in 125 I]-S70254 showed higher specific binding in the periacqueductal gray region (1.93 6 2.00 vs. 0.25 6 0.51 fmol·mg protein 21 , respectively), in the interpeduncular nucleus (4.14 6 4.52 vs. 1.56 6 0.31 fmol·mg protein 21 ), and in olfactory bulbs (4.88 vs. 2.24 fmol·mg protein 21 ). In the subiculum and pontine nuclei, we observed only [
125 I]-S70254 binding (3.05 6 3.17 and 3.10 6 2.33 fmol·mg protein 21 , respectively). In the suprachiasmatic nuclei and pars tuberalis, we observed only 2-[ 125 I]-MLT binding (4.07 and 14.24 fmol·mg protein 21 , respectively). Representative images are shown in Fig. 4 .
Rat and sheep retina autoradiography. To complete our characterization of these new radioligands, we also assessed binding of 2-[ 125 I]-MLT and [ 125 I]-S70254 in rat and sheep retinas (Fig. 5) side chain of MLT) does not affect the hydrogen bonding potential with the 5-methoxy oxygen atom and the amide group on the side chain, as previously described (Pala et al., 2013) . The iodine and the naphthyl (S70254) on the indole C2 position have a similar hydrophobic shape in the vicinity of the indole ring. Furthermore, the second aromatic of the naphthyl group likely confers the MT 2 selectivity to S70254. On the side chain of compounds S70254 and SD6, the iodine atom does not prevent the amide group from making hydrogen bonds to the receptor, suggesting a hydrophobic pocket in that region.
Discussion
One main factor limiting studies of the melatonin receptors MT 1 and MT 2 is the lack of antagonist and discriminant radioligands. The two presently known radioligands, [
3 H]-MLT and 2-[ 125 I]-MLT, are pure agonists, and exhibit the same affinity and almost identical pharmacological parameters for both receptors (Browning et al., 2000; Masana and Dubocovich, 2001; Legros et al., 2013 Legros et al., , 2014 . In the present work, we described three new radioligands that can be used for MT 1 and MT 2 receptor characterization. Our results indicated that each radioligand has specific properties that can be exploited for different kinds of pharmacological studies. In particular, we found that [
125 I]-S70254 is specific for the MT 2 receptor, and can be used with cells and tissue.
The three newly investigated radioligands could each bind hMT 1 and/or hMT 2 receptors. Specifically, [ ]-DIV880 each showed a slightly lower affinity (half-log lower) for the hMT 2 receptor, although this difference disappeared when using the kinetics pK d . The lower affinity could be explained by the difficulty reaching a saturation plateau in the Scatchard assay. Apart from the lack of affinity for hMT 1 
New Melatonin Receptor Radioligands
Our kinetics experiments illustrated the ability of the radiocompound to associate and dissociate from the receptor. After 1 hour of incubation at room temperature, 2-[ 125 I]-MLT did not reach an equilibrium plateau, and only a proportion was bound to a receptor (3/4 with hMT 1 and 1/2 with hMT 2 ).
The 2-[
125 I]-MLT radioligand has been widely used to study melatonin receptors in the brain and peripheral organs by autoradiography Thomas et al., 2002; Sallinen et al., 2005) . Usually an incubation time of about 1 hour is used, which allows a balance between radioligand (de Reviers et al., 1991) .
The use of alternative radioligands could potentially help with this problem of partial binding site labeling. In the present work, we showed that such autoradiography experiments could be performed, and could lead to new specific information about MT 2 localization. The ligand 2-[
125 I]-MLT shows similar affinities for both receptors as well as similar kinetics, making it a poor selection for autoradiography. On the other hand, [
3 H]-MLT has the advantage of fast association kinetics but also shows a very low specific activity that also makes it a poor candidate for autoradiography. We found that [ (Paxinos and Watson, 1997) , or it could have been because the rat MT 2 expression was too low and the reinforcement of this problem by the partial labeling of the receptors by the radioligand with an incubation time of 1 hour.
In our assays using the retina membrane preparation, we observed specific binding with 2-[ 125 I]-MLT and [ 125 I]-SD6. Sheep retina tissue expresses both the ovine MT 1 and MT 2 receptors (Coge et al., 2009 ). In comparison with the K d value on transfected cell membrane preparations, the first highest affinity binding site could be oMT 1 or oMT 2 in sheep retina tissue (Mailliet et al., 2004) . The second binding site in the saturation experiment remains to be identified. The binding of [ 125 I]-S70254 was highly variable, and the saturation curve was difficult to obtain. This may have been due to the low density of the oMT 2 receptor, which could potentially be remedied by increasing the protein concentration only if we also changed the filtration protocol, as filter obstruction would occur with the presently used protocol. Another possible cause is the affinity of the radioligand for the ovine form of the receptor (K iovine 5 7.67 6 0.07, unpublished data). This could be investigated by performing tests with tissue membrane preparations from different species.
It is unfortunately clear that, as of today, the use of [ 125 I]-SD6 would not determine other information than that determined by 2-[ 125 I]-MLT. It remains to be seen if further characterization of the agonistic nature of the compound, using as many different signaling pathways, will reveal a different view of these agonists (C. Legros and J.A. Boutin, manuscript in preparation) .
Overall, our present data contribute information and potential new tools that will be useful in further studies of MLT molecular pharmacology. Greater availability of such tools would help pharmacologists to better understand the nature of involvement of MLT receptors in the many pathologic processes in which MLT is active. However, further structure-based modeling will be required to design new agonist compounds and to better understand the structure mechanism of the various action relationships (agonist, partial agonist, and antagonist) that can, incidentally, serve as radioligands after iodination. Continued investigations of this field and the development of new techniques could lead to novel therapies targeting the melatonergic system.
